Genoil (GNOLF) Accumulated Expenses (2009 - 2025)

Genoil (GNOLF) has 15 years of Accumulated Expenses data on file, last reported at $72256.0 in Q4 2025.

• On a quarterly basis, Accumulated Expenses rose 87.13% year-over-year to $72256.0 in Q4 2025; TTM through Dec 2025 was $72256.0, a 87.13% increase from a year earlier, with the FY2025 full-year figure at $72256.0, up 87.13% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $72256.0, up from $62005.0 in the prior quarter.
• Over the last five years, Accumulated Expenses for GNOLF reached as high as $6.3 million in Q2 2023 and fell as low as $3945.0 in Q3 2023.
• Historically, Accumulated Expenses has averaged $2.2 million across 5 years, with a median of $72256.0 in 2025.
• Across the five-year window, Accumulated Expenses tumbled 99.92% in 2023 and surged 673.05% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $4.1 million in 2021, then jumped by 37.43% to $5.6 million in 2022, then plunged by 99.82% to $10406.0 in 2023, then soared by 271.06% to $38612.0 in 2024, then surged by 87.13% to $72256.0 in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $72256.0 in Q4 2025, $62005.0 in Q3 2025, and $53890.0 in Q2 2025.